Health-related quality of life in Waldenstrom Macroglobulinemia and IgM-related disorders: A single institution experience

Hematol Oncol. 2020 Feb;38(1):111-113. doi: 10.1002/hon.2699. Epub 2019 Dec 18.

Authors

Anna Maria Frustaci¹, Michele Nichelatti¹, Marina Deodato¹, Giulia Zamprogna¹, Periana Minga¹, Maria Luisa Pioltelli¹, Roberto Cairoli¹, Alessandra Tedeschi¹

Affiliation

¹ ASST Grande Ospedale Metropolitano Niguarda, Department of Hematology, Niguarda Cancer Center, Milan, Italy.

PMID: 31852014
DOI: 10.1002/hon.2699

No abstract available

Publication types

Clinical Trial
Letter

MeSH terms

Aged
Female
Follow-Up Studies
Humans
Immunoglobulin M / immunology*
Male
Middle Aged
Monoclonal Gammopathy of Undetermined Significance / immunology
Monoclonal Gammopathy of Undetermined Significance / therapy*
Multiple Myeloma / immunology
Multiple Myeloma / therapy*
Peripheral Nervous System Diseases / immunology
Peripheral Nervous System Diseases / therapy*
Prognosis
Quality of Life*
Surveys and Questionnaires
Waldenstrom Macroglobulinemia / immunology
Waldenstrom Macroglobulinemia / therapy*

Substances

Immunoglobulin M